TIL THERAPY VS
IMMUNOTHERAPY
If immunotherapy has stopped working, TIL therapy may still be an option โ it operates through completely different biology. Here is what you need to understand.
What Conventional Immunotherapy Does
Checkpoint inhibitors โ pembrolizumab, nivolumab, atezolizumab โ block proteins like PD-1 or CTLA-4 that cancer cells use to send a "stand down" signal to the immune system. They do not add new immune cells; they remove a brake, allowing the immune system already present to respond more aggressively.
โCheckpoint inhibitors release a brake. TIL therapy introduces an entirely new immune force.โ
Where TIL Therapy Comes In
TIL therapy does not release brakes. It introduces billions of tumor-educated immune cells that operate independently of the pathways targeted by checkpoint inhibitors. The resistance mechanism that overcame a PD-1 drug is not the same mechanism that TIL cells rely on โ which is exactly why prior immunotherapy failure does not predict TIL therapy failure. The melanoma clinical data demonstrated this directly: a meaningful proportion of patients who progressed on anti-PD-1 therapy still had measurable responses to TIL therapy.
TIL Therapy vs Checkpoint Immunotherapy
The delivery, personalization, physical requirements, and mechanisms differ substantially.
TIL Therapy
- Made from your tumorCells extracted from your specific cancer tissue โ deeply personalized.
- Requires hospitalizationWeeks of manufacturing + inpatient admission for infusion and IL-2 support.
- Active after immunotherapy failureStudied and approved specifically in patients who progressed on PD-1 drugs.
Checkpoint Immunotherapy
- Same drug across patientsNot personalized to individual tumor biology or immune profile.
- Outpatient infusionsEvery few weeks as an outpatient โ far less intensive delivery.
- Limited after resistance developsOnce cancer adapts to checkpoint blockade, options in this pathway narrow.
TIL Therapy After Immunotherapy โ Key Data
- ~31%ORR in PD-1 FailuresObjective response rate in melanoma patients who had already failed anti-PD-1 immunotherapy.
- 2024FDA Approval YearLifileucel approved specifically for patients who progressed after immunotherapy.
- DifferentResistance MechanismImmunotherapy resistance does not cross over to TIL therapy โ they work through different biology.
How These Treatments Fit Together
Some patients receive immunotherapy, respond durably, and never need to think about TIL therapy. Others use immunotherapy as a first step and TIL therapy as the next line. Others come to TIL therapy because immunotherapy was never appropriate for their tumor type. There is no single path โ which is why understanding the distinction between these approaches matters.
Related TIL Therapy Topics
Continue reading the CancerFax TIL Therapy guide series.
Frequently Asked Questions
TIL Therapy After Immunotherapy
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination โ travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Has Immunotherapy Stopped Working for You?
Upload your medical reports for a specialist case evaluation. TIL therapy may still be an option โ it works through entirely different biology than the treatments you have already tried.
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified oncologist before making treatment decisions.